Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase II Study of Heme Arginate in Patients Planned for Cardiac Surgery

Trial Profile

Phase II Study of Heme Arginate in Patients Planned for Cardiac Surgery

Completed
Phase of Trial: Phase II

Latest Information Update: 28 Feb 2017

At a glance

  • Drugs Haem arginate (Primary)
  • Indications Acute kidney injury
  • Focus Pharmacogenomic; Therapeutic Use
  • Acronyms HACS
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 09 Dec 2015 Status changed from recruiting to completed according to United Kingdom Clinical Research Network record.
    • 27 Nov 2015 Accrual to date is 105% according to United Kingdom Clinical Research Network record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top